Capricor Therapeutics, Inc. earnings per share and revenue

CAPR earnings per share for the last quarter are -0.35 USD whereas the estimation was -0.36 USD which accounts for 1.69% surprise. Company revenue for the same period amounts to 3.97 M USD despite the estimated figure of 4.58 M USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 4.28 M USD. Also watch annual changes over time to get a bigger picture of CAPR earnings per share and revenue dynamics.